SAGE Therapeutics (SAGE) Reports Q1 Net Loss of $122.1M

May 3, 2022 6:40 AM EDT

SAGE Therapeutics (NASDAQ: SAGE) reported Q1 net loss of $122.1 million. Revenue for the quarter came in at $1.6 million versus the consensus estimate of $3.21 million.

For earnings history and earnings-related data on SAGE Therapeutics (SAGE) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities